GenMont Biotech Incorporation (TPE:3164)
Taiwan
· Delayed Price · Currency is TWD 17.75
-0.20 (-1.11%)
Apr 29, 2026, 1:30 PM CST
TPE:3164 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,527 | 1,578 | 1,748 | 2,137 | 2,047 | 2,103 | Upgrade
|
| Market Cap Growth | -14.13% | -9.68% | -18.22% | 4.39% | -2.67% | 9.23% | Upgrade
|
| Enterprise Value | 1,390 | 1,481 | 1,706 | 2,022 | 1,818 | 1,937 | Upgrade
|
| Last Close Price | 17.75 | 17.56 | 18.64 | 22.33 | 20.85 | 20.48 | Upgrade
|
| PE Ratio | 26.89 | 27.59 | 30.52 | 64.77 | 35.93 | 18.59 | Upgrade
|
| PS Ratio | 3.81 | 3.93 | 4.54 | 6.72 | 5.55 | 4.92 | Upgrade
|
| PB Ratio | 1.05 | 1.09 | 1.18 | 1.48 | 1.37 | 1.38 | Upgrade
|
| P/TBV Ratio | 1.15 | 1.19 | 1.30 | 1.63 | 1.52 | 1.53 | Upgrade
|
| P/FCF Ratio | 21.75 | 22.49 | 21.87 | 1655.18 | 31.11 | - | Upgrade
|
| P/OCF Ratio | 20.74 | 21.45 | 14.10 | 61.76 | 14.94 | 18.84 | Upgrade
|
| EV/Sales Ratio | 3.47 | 3.69 | 4.43 | 6.36 | 4.93 | 4.53 | Upgrade
|
| EV/EBITDA Ratio | 11.19 | 12.29 | 15.77 | 29.39 | 16.54 | 13.54 | Upgrade
|
| EV/EBIT Ratio | 24.08 | 25.65 | 41.98 | 289.29 | 29.34 | 15.49 | Upgrade
|
| EV/FCF Ratio | 19.81 | 21.10 | 21.35 | 1565.86 | 27.64 | - | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.08 | 0.08 | 0.04 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.89 | 0.89 | 1.06 | 0.81 | 0.31 | 0.22 | Upgrade
|
| Debt / FCF Ratio | 1.57 | 1.57 | 1.49 | 45.16 | 0.53 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.18 | -0.16 | -0.19 | -0.24 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.12 | -2.12 | -2.22 | -3.93 | -3.33 | -2.72 | Upgrade
|
| Net Debt / FCF Ratio | -3.63 | -3.63 | -3.00 | -209.14 | -5.57 | 73.63 | Upgrade
|
| Asset Turnover | 0.24 | 0.24 | 0.23 | 0.19 | 0.22 | 0.26 | Upgrade
|
| Inventory Turnover | 2.02 | 2.02 | 1.78 | 1.49 | 2.42 | 3.58 | Upgrade
|
| Quick Ratio | 3.18 | 3.18 | 2.80 | 2.52 | 2.82 | 3.43 | Upgrade
|
| Current Ratio | 4.28 | 4.28 | 3.87 | 3.18 | 3.24 | 4.17 | Upgrade
|
| Return on Equity (ROE) | 3.28% | 3.28% | 3.26% | 1.52% | 3.14% | 7.29% | Upgrade
|
| Return on Assets (ROA) | 2.14% | 2.14% | 1.51% | 0.26% | 2.28% | 4.72% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.66% | 3.57% | 2.48% | 0.48% | 3.92% | 8.99% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 3.80% | 2.60% | 0.50% | 4.00% | 8.00% | Upgrade
|
| Earnings Yield | 3.75% | 3.62% | 3.28% | 1.54% | 2.78% | 5.38% | Upgrade
|
| FCF Yield | 4.60% | 4.45% | 4.57% | 0.06% | 3.21% | -0.25% | Upgrade
|
| Dividend Yield | 4.46% | 4.56% | 4.29% | 2.24% | 3.36% | 5.37% | Upgrade
|
| Payout Ratio | 121.00% | 121.00% | 75.56% | 183.26% | 166.75% | 53.42% | Upgrade
|
| Buyback Yield / Dilution | 0.23% | 0.23% | -0.18% | 0.10% | 0.09% | 1.50% | Upgrade
|
| Total Shareholder Return | 4.70% | 4.79% | 4.11% | 2.34% | 3.45% | 6.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.